# Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

> **NCT00311714** · PHASE1 · COMPLETED · sponsor: **Biota Scientific Management Pty Ltd** · enrollment: 40 (—)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** CS-8958 formulated as dry powder
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00311714
- **Lead sponsor:** Biota Scientific Management Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 40 (—)
- **Last updated:** 2018-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311714, "Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00311714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*